Ekso Bionics Holdings, Inc. (EKSO) Shares Gap Down to $2.02

Ekso Bionics Holdings, Inc. (NASDAQ:EKSO)’s share price gapped down before the market opened on Wednesday . The stock had previously closed at $2.22, but opened at $2.02. Ekso Bionics Holdings shares last traded at $1.75, with a volume of 2851800 shares changing hands.

Separately, Zacks Investment Research upgraded Ekso Bionics Holdings from a “hold” rating to a “buy” rating and set a $2.00 price objective on the stock in a research report on Wednesday, July 26th.

The company has a quick ratio of 5.73, a current ratio of 6.09 and a debt-to-equity ratio of 0.18.

Ekso Bionics Holdings (NASDAQ:EKSO) last posted its quarterly earnings results on Wednesday, November 8th. The company reported ($0.18) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.13) by ($0.05). Ekso Bionics Holdings had a negative return on equity of 323.00% and a negative net margin of 343.53%. The company had revenue of $1.60 million for the quarter, compared to the consensus estimate of $2.40 million. equities research analysts forecast that Ekso Bionics Holdings, Inc. will post -0.81 EPS for the current fiscal year.

Institutional investors and hedge funds have recently bought and sold shares of the stock. Carl Domino Inc grew its position in Ekso Bionics Holdings by 74.7% during the 2nd quarter. Carl Domino Inc now owns 82,054 shares of the company’s stock worth $190,000 after acquiring an additional 35,088 shares during the last quarter. National Planning Corp grew its position in Ekso Bionics Holdings by 116.2% during the 2nd quarter. National Planning Corp now owns 234,450 shares of the company’s stock worth $537,000 after acquiring an additional 126,000 shares during the last quarter. Intellectus Partners LLC grew its position in Ekso Bionics Holdings by 5.3% during the 2nd quarter. Intellectus Partners LLC now owns 105,294 shares of the company’s stock worth $244,000 after acquiring an additional 5,294 shares during the last quarter. Finally, Vanguard Group Inc. grew its position in Ekso Bionics Holdings by 32.9% during the 2nd quarter. Vanguard Group Inc. now owns 711,082 shares of the company’s stock worth $1,650,000 after acquiring an additional 176,197 shares during the last quarter. Institutional investors and hedge funds own 2.85% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This article was first published by Markets Daily and is owned by of Markets Daily. If you are reading this article on another domain, it was copied illegally and reposted in violation of United States and international copyright & trademark laws. The correct version of this article can be read at https://www.themarketsdaily.com/2017/11/16/ekso-bionics-holdings-inc-ekso-shares-gap-down-to-2-02.html.

Ekso Bionics Holdings Company Profile

Ekso Bionics Holdings, Inc designs, develops, and sells exoskeletons for use in the healthcare, industrial, military, and consumer markets in North America, Europe, the Middle East, and Africa. The company operates through Medical Devices, Industrial Sales, and Engineering Services segments. It primarily offers Ekso GT, a bionic suit that provides the ability to stand and walk over ground with a reciprocal gait using a cane, crutches, or a walker to individuals with spinal cord injuries, hemiplegia due to stroke, and lower limb paralysis or weakness.

Receive News & Ratings for Ekso Bionics Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ekso Bionics Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply